Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.
Monitoring and Pharmacological Treatment
Patients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5 years, while moderate MR warrants an echocardiogram every 1-2 years. Severe MR requires more frequent monitoring, typically every 6-12 months.
Pharmacological management is crucial for severe MR. Diuretics are prescribed to reduce fluid overload and alleviate pulmonary edema, although they do not address the underlying regurgitation. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) help relax blood vessels, reduce afterload, and decrease the volume of regurgitant blood flow. Beta-blockers reduce heart rate and improve the efficiency of heartbeats. If atrial fibrillation is present, anticoagulants are necessary to prevent thromboembolic events, including stroke. Adopting a low-sodium diet and moderating physical activity can further help manage symptoms.
Surgical Interventions
If symptoms of heart failure persist, surgical intervention may be necessary. Several surgical options are available, depending on the specific condition of the mitral valve:
Mitral regurgitation, or MR, treatment depends on the condition's severity, symptoms, and the underlying cause.
Patients with mild or moderate MR typically require regular monitoring but no specific interventions.
For severe MR, pharmacological treatment helps manage symptoms and reduce complications.
Medications such as diuretics relieve fluid overload and pulmonary edema.
Angiotensin-converting enzyme, ACE inhibitors, and angiotensin II receptor blockers reduce cardiac afterload and slow the progression of left ventricular dysfunction.
Beta-blockers help control heart rate and improve cardiac output.
Additionally, anticoagulants are necessary for patients with atrial fibrillation to prevent thromboembolic events.
Lifestyle modifications, such as a low-sodium diet, may also be beneficial, and activity should be limited if symptoms develop.
If any heart failure symptoms persist, it may indicate the need for surgical intervention, such as annuloplasty or valvuloplasty.
Lastly, mitral valve replacement with a mechanical or tissue valve is sometimes required.
繁體中文
